134 related articles for article (PubMed ID: 2846575)
1. Solubilization of the active vasoactive intestinal peptide receptor from human colonic adenocarcinoma cells.
el Battari A; Martin JM; Luis J; Pouzol O; Secchi J; Marvaldi J; Pichon J
J Biol Chem; 1988 Nov; 263(33):17685-9. PubMed ID: 2846575
[TBL] [Abstract][Full Text] [Related]
2. Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29.
Couvineau A; Rousset M; Laburthe M
Biochem J; 1985 Oct; 231(1):139-43. PubMed ID: 2998337
[TBL] [Abstract][Full Text] [Related]
3. Characterization and solubilization of vasoactive intestinal peptide receptors from rat lung membranes.
Provow S; Veliçelebi G
Endocrinology; 1987 Jun; 120(6):2442-52. PubMed ID: 3032591
[TBL] [Abstract][Full Text] [Related]
4. Characterization of receptors for vasoactive intestinal peptide solubilized from the lung.
Paul S; Said SI
J Biol Chem; 1987 Jan; 262(1):158-62. PubMed ID: 3025200
[TBL] [Abstract][Full Text] [Related]
5. Covalent cross-linking of vasoactive intestinal peptide (VIP) to its receptor in intact colonic adenocarcinoma cells in culture (HT 29).
Muller JM; Luis J; Fantini J; Abadie B; Giannellini F; Marvaldi J; Pichon J
Eur J Biochem; 1985 Sep; 151(2):411-7. PubMed ID: 2992966
[TBL] [Abstract][Full Text] [Related]
6. Solubilization of rat lung vasoactive intestinal peptide receptors in the active state. Characterization of the binding properties and comparison with membrane-bound receptors.
Patthi S; Simerson S; Veliçelebi G
J Biol Chem; 1988 Dec; 263(36):19363-9. PubMed ID: 2848823
[TBL] [Abstract][Full Text] [Related]
7. A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 1. Molecular characterization of the binding site.
Luis J; Martin JM; el Battari A; Reynier M; Marvaldi J; Pichon J
Eur J Biochem; 1989 Mar; 180(2):429-33. PubMed ID: 2538330
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
Gespach C; Bawab W; de Cremoux P; Calvo F
Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous solubilization of high-affinity receptors for VIP and glucagon and of a low-affinity binding protein for VIP, shown to be identical to calmodulin.
Andersson M; Carlquist M; Maletti M; Marie JC
FEBS Lett; 1993 Feb; 318(1):35-40. PubMed ID: 8382169
[TBL] [Abstract][Full Text] [Related]
10. Characterization of vasoactive intestinal peptide receptors in rat seminal vesicle.
Guijarro LG; Rodriguez-Pena MS; Prieto JC
Am J Physiol; 1991 Feb; 260(2 Pt 1):E286-91. PubMed ID: 1847588
[TBL] [Abstract][Full Text] [Related]
11. Solubilization of the liver vasoactive intestinal peptide receptor. Hydrodynamic characterization and evidence for an association with a functional GTP regulatory protein.
Couvineau A; Amiranoff B; Laburthe M
J Biol Chem; 1986 Nov; 261(31):14482-9. PubMed ID: 3021741
[TBL] [Abstract][Full Text] [Related]
12. Hydrodynamic characterization of vasoactive intestinal peptide receptors extracted from rat lung membranes in Triton X-100 and n-octyl-beta-D-glucopyranoside.
Patthi S; Akong M; Veliçelebi G
J Biol Chem; 1987 Nov; 262(32):15740-5. PubMed ID: 2824466
[TBL] [Abstract][Full Text] [Related]
13. Characterization of receptors for VIP on pancreatic acinar cell plasma membranes using covalent cross-linking.
McArthur KE; Wood CL; O'Dorisio MS; Zhou ZC; Gardner JD; Jensen RT
Am J Physiol; 1987 Mar; 252(3 Pt 1):G404-12. PubMed ID: 2435170
[TBL] [Abstract][Full Text] [Related]
14. Molecular characteristics and peptide specificity of vasoactive intestinal peptide receptors from rat cerebral cortex.
Couvineau A; Gammeltoft S; Laburthe M
J Neurochem; 1986 Nov; 47(5):1469-75. PubMed ID: 3020175
[TBL] [Abstract][Full Text] [Related]
15. Solubilization of active and stable receptors for vasoactive intestinal peptide from rat liver.
Guijarro L; Couvineau A; Calvo JR; Laburthe M
Regul Pept; 1989 Apr; 25(1):37-50. PubMed ID: 2541470
[TBL] [Abstract][Full Text] [Related]
16. Vasoactive intestinal peptide receptor on liver plasma membranes: solubilization and cross-linking.
Nguyen TD; Kaiser LM
Peptides; 1990; 11(6):1255-61. PubMed ID: 1965036
[TBL] [Abstract][Full Text] [Related]
17. Cycloheximide induces accumulation of vasoactive intestinal peptide (VIP) binding sites at the cell surface of a human colonic adenocarcinoma cell line (HT29-D4). Evidence for the presence of an intracellular pool of VIP receptors.
Luis J; Martin JM; el Battari A; Fantini J; Giannellini F; Marvaldi J; Pichon J
Eur J Biochem; 1987 Sep; 167(2):391-6. PubMed ID: 3040409
[TBL] [Abstract][Full Text] [Related]
18. Characterization of vasoactive intestinal peptide receptors on rat alveolar macrophages.
Sakakibara H; Shima K; Said SI
Am J Physiol; 1994 Sep; 267(3 Pt 1):L256-62. PubMed ID: 7943252
[TBL] [Abstract][Full Text] [Related]
19. Evidence for vasoactive intestinal peptide receptors in apical membranes from tracheal epithelium.
Elgavish A; Pillion DJ; Meezan E
Life Sci; 1989; 44(15):1037-42. PubMed ID: 2538697
[TBL] [Abstract][Full Text] [Related]
20. Photoaffinity labelling of the vasoactive-intestinal-peptide-binding site on intact human colonic adenocarcinoma cell line HT29-D4. Synthesis and use of photosensitive vasoactive-intestinal-peptide derivatives.
Martin JM; Darbon H; Luis J; el Battari A; Marvaldi J; Pichon J
Biochem J; 1988 Mar; 250(3):679-85. PubMed ID: 2839143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
